The Referee Who Wasn’t There: The Ghostly Tale of Reviewer 3
The power and identity of Reviewer 3 springs from the shadows to ensnare the unwanted paper. But is it really a powerful spirit? Or just Dad in a mask?
The power and identity of Reviewer 3 springs from the shadows to ensnare the unwanted paper. But is it really a powerful spirit? Or just Dad in a mask?
Vitriol may have obscured important points in a post last week. The growing business strategy of our era is to drive the cost of everyone else’s product to zero in order to make more money from your own product. This imbalance stifles innovation and creation.
Yes, American baseball is a subtle game full of grass, dirt, leather, and wood. But if you’re a cricket fan, it can be downright bewildering. This video will show you how we feel about cricket.
A recent book tells the story of how technology companies — in the guise of advocates of “open” — have gutted content and culture businesses and the creative ranks that depend on them.
An interview with Fred Dylla of the American Institute of Physics, and why funding is at the heart of many issues we currently face.
With the speed of communication today, researchers, authors, and grant funders are impatient to get an indicator of its value. Waiting 1-3 years for publication and citation seems interminable. Conflating an article’s impact with its journals’ impact creates uncertainty, as […]
Libraries generate a great deal of information about their own processes, including circulation records. Making that information available to others could be the basis for a consortium to share and market such library data.
Every scholarly publisher in the world suddenly has less that a year to decide what to do with article submissions from the UK. The new Research Council UK (RCUK) mandate applies to all articles submitted beginning April 1, 2013. Do […]
When it comes to self-archiving final manuscripts, NIH-funded authors either do not understand–or blatantly disregard–government and publisher policy. What can be done?
The University of Missouri saga has many lessons for publishers of all types. But perhaps the harshest lesson is that we’re in a tough business.
An attempt to list a bunch of things journal publishers do. It’s not perfect, but it’s better than nothing.
The EU follows in lockstep with the UK, with a statement instead of a mandate. Are the gloves about to come off?
For some time I have been working on a basic model of scientific progress (or, since “progress” is a value-loaded term, a model of how science progresses). It has implications for certain issues related to scientific publication, so I thought […]
A lurid story of intramural hijinks at the FDA shows how far from mission an organization can drift when it gets its priorities wrong.
The RCUK announces its OA plans, including a six-month embargo. Now, speculation snaps into reality, and we will see if a number of lurking unintended consequences come to pass.